RESUMO
OBJECTIVE: Five to 7% of breast cancers affect women under 40 years old. The survival of these patients has been improved thanks to therapeutic advances, often to the detriment of their fertility. The objective of this study is to evaluate the activity of oncofertility and the future of young women with breast cancer managed at the Montpellier University Hospital. METHODS: This is a retrospective study including women aged from 18 to 43 years-old diagnosed with breast cancer and referred in oncofertility consultation at the Montpellier University Hospital between July 2011 and December 2018. RESULTS: 190 patients were eligible, three refused to participate to the study, hence 187 patients were included. We estimate that only 33% of young breast cancer patients potentially eligible for fertility preservation (FP) benefited from an oncofertility consultation in our region. Of these 187 patients, 58 (31%) underwent ovarian stimulation for oocyte or embryo vitrification. They were significantly younger: 32.9 vs 34.6 years old (P=0.01) and had fewer invaded lymph nodes. A total of 66 cycles were achieved and 11.4 oocytes or 3 embryos were vitrified per patient. The reuse rate was 3.6% with 91% of post cancer pregnancies being spontaneous. CONCLUSION: The oncofertility care network seems effective at the regional level. Enhancing health professionals' awareness and creating a regional register could improve our long-term follow-up.
Assuntos
Neoplasias da Mama , Preservação da Fertilidade , Adolescente , Adulto , Neoplasias da Mama/terapia , Feminino , Hospitais Universitários , Humanos , Gravidez , Estudos Retrospectivos , Vitrificação , Adulto JovemRESUMO
The frequency of polycystic ovary syndrome (PCOS) and the consequent fertility disorders cause many difficulties in the management of the assisted reproductive technics. Some studies are focused on different additional treatments, stimulation protocols or techniques that could optimize the in vitro fertilization cycles. The quality of the oocytes and embryos of these patients is also an outstanding issue. They remain difficult to actually evaluate during management, and none of the few published studies on this subject demonstrated any inferiority, compared to control patients. However, many differences have been highlighted, studying intra- and extra-ovarian factors. The advent of new genetic techniques could allow a better understanding of the pathophysiological mechanisms of the syndrome, as well as refining the evaluation of oocytes and embryos, in order to better predict the results of in vitro fertilization attempts. Pregnancy and birth rates, however, appear to be comparable to those of the general population.
Assuntos
Embrião de Mamíferos/fisiologia , Fertilização in vitro , Infertilidade Feminina/etiologia , Oócitos/fisiologia , Síndrome do Ovário Policístico/complicações , Blastocisto/fisiologia , Feminino , Humanos , Infertilidade Feminina/fisiopatologia , Infertilidade Feminina/terapia , Síndrome do Ovário Policístico/genética , Síndrome do Ovário Policístico/fisiopatologia , Gravidez , Injeções de Esperma Intracitoplásmicas , Resultado do TratamentoRESUMO
Circulating or "extracellular" microRNAs (miRNAs) detected in biological fluids, could be used as potential diagnostic and prognostic biomarkers of several disease, such as cancer, gynecological and pregnancy disorders. However, their contributions in female infertility and in vitro fertilization (IVF) remain unknown. This study investigated the expression profiles of five circulating miRNAs (let-7b, miR-29a, miR-30a, miR-140 and miR-320a) in human follicular fluid from 91 women with normal ovarian reserve and 30 with polycystic ovary syndrome (PCOS) and their ability to predict IVF outcomes. The combination of FF miR-30a, miR-140 and let-7b expression levels discriminated between PCOS and normal ovarian reserve with a specificity of 83.8% and a sensitivity of 70% (area under the ROC curve, AUC = 0.83 [0.73-0.92]; p < 0.0001). FF samples related to low number of mature oocytes (≤2) contained significant less miR-320a levels than those related to a number of mature oocytes >2 (p = 0.04). Moreover, FF let-7b predicted the development of expanded blastocysts with 70% sensitivity and 64.3% specificity (AUC = 0.67 [0.54-0.79]; p = 0.02) and FF miR-29a potential to predict clinical pregnancy outcome reached 0.68 [0.55-0.79] with a sensitivity of 83.3% and a specificity of 53.5% (p = 0.01). Therefore, these miRNAs could provide new helpful biomarkers to facilitate personalized medical care during IVF.
Assuntos
MicroRNA Circulante/análise , Testes Diagnósticos de Rotina/métodos , Fertilização in vitro , Líquido Folicular/química , Síndrome do Ovário Policístico/diagnóstico , Adulto , Feminino , Humanos , Medicina de Precisão/métodos , Sensibilidade e Especificidade , Adulto JovemRESUMO
OBJECTIVE: This study intended to compare frozen embryo transfer (FET) outcomes at blastocyst stage according to freezing methods, slow freezing versus vitrification and according to the type of endometrial preparation. PATIENTS AND METHODS: A total of 172 FET at blastocyst stage (day 5 or 6) were included retrospectively from April, 2007 to December, 2012. The FET outcomes from slow freezing (group 1, n=86) were compared with those from vitrification (group 2, n=86). More particularly, the survival rate after thawing, as well as implantation and pregnancy rates (clinical and ongoing pregnancy rates) were compared respectively between these two groups, after matching on women's age at freezing day, embryo number and embryo development stage for transfer. Furthermore, for each freezing method, FET outcomes were compared according to the type of endometrial preparation, i.e. natural cycle (group N) versus stimulated cycle (group S). RESULTS: The survival rate as well as implantation and clinical pregnancy rates were significantly higher for FET after vitrification compared to FET after slow freezing (97% vs 85%, P<0.0001; 32% vs 20%, P=0.02; 43% vs 28%, P=0.04, respectively). By taking into account the number of transferred embryos for each group, the multiple pregnancy rate was three-fold higher in the group of FET after vitrification compared to the group of FET after slow freezing but not significantly (27.3% vs 8.3%, NS). However, FET outcomes were not affected significantly by the type of endometrial preparation whatever freezing methods. Nevertheless, the early spontaneous abortion (ESA) rate was lower in the case of embryos that were frozen by vitrification and transferred in natural cycle (group N2 vs group S2: 20% vs 47%, NS). DISCUSSION AND CONCLUSION: Our study confirms that the survival rate after thawing at blastocyst stage (day 5 or 6) is significantly improved after freezing by vitrification compared to slow freezing method. Likewise, implantation and clinical pregnancy rates are significantly increased in the case of FET at blastocyst stage when these embryos were frozen by vitrification. The results obtained by vitrification are very satisfactory but are also associated with an increased multiple pregnancy rate. Moreover, FET associated with natural or stimulated cycle does not modify significantly the outcomes of attempts, whatever the freezing method. However, the risk of ESA is reduced in the case of FET with natural cycle and after embryo vitrification.
Assuntos
Blastocisto/fisiologia , Criopreservação/métodos , Transferência Embrionária/métodos , Endométrio/fisiologia , Adulto , Implantação do Embrião , Desenvolvimento Embrionário , Feminino , Humanos , Gravidez , Taxa de Gravidez , Estudos RetrospectivosRESUMO
OBJECTIVE: Female fertility preservation in the context of cancer management is crucial for patient's health care. The aim of this study was to evaluate the oncofertility practice at our university hospital of Montpellier since 2011. PATIENTS AND METHODS: The evaluation of management of young patients referred to Montpellier University Hospital from September 2011 to September 2013 for oncofertility counselling before cancer treatment. RESULTS: Seventy-one patients were referred to a specialized oncofertility center. Forty-two patients (59.1%) were included in the oncofertility program. Twenty-two patients (31%) were proposed for oocyte vitrification after COS protocol, eight patients (11.3%) for ovarian tissue cryoconservation, seven patients (9.9%) for GnRH injections, three patients (4.2%) ovarian transposition and two patients (2.8%) for embryo cryopreservation. Among the 42 indications of fertility preservation, only 18 will have finally taken place. CONCLUSION: Oncofertility counselling for young patients should now be part of the cancer management. It involves multidisciplinary teams. Further information of both oncologists and patients is needed to improve this new approach in the field of cancer treatments.
Assuntos
Gerenciamento Clínico , Preservação da Fertilidade/métodos , Hospitais Universitários/estatística & dados numéricos , Neoplasias/reabilitação , Encaminhamento e Consulta/estatística & dados numéricos , Adulto , Feminino , Preservação da Fertilidade/estatística & dados numéricos , França , Humanos , Avaliação de Programas e Projetos de Saúde , Adulto JovemRESUMO
OBJECTIVE: To evaluate the effect of induced blastocoele shrinkage before vitrification in a closed carrier device. PATIENTS AND METHODS: Prior to vitrification, blastocyst cavity was artificially shrinked by laser pulse or not treated according to a 2:1 randomized procedure. A total of 185 warming cycles from April 2011 to March 2013 have been analyzed. Clinical pregnancy rate and survival rate were compared between the two groups. The mean (±SD) women age was 33.5±5.7 years for both groups. RESULTS: The pregnancy rate in the group with artificial reduction of the cavity was higher ([32/67] 47.7%) than in the control group but not significantly ([43/113] 38%). The survival rate in the artificial shrinkage group was significantly higher compared with the control group : 99% (102/103) and 91.8% (168/183) respectively (P=0.01). DISCUSSION AND CONCLUSION: This study reveals that artificial shrinkage of blastocoelic cavity by laser pulse before vitrification in a closed carrier device improves survival rate after warming.
Assuntos
Blastocisto/fisiologia , Blastocisto/ultraestrutura , Criopreservação/métodos , Adulto , Criopreservação/instrumentação , Transferência Embrionária , Feminino , Fertilização in vitro/métodos , Temperatura Alta , Humanos , Gravidez , Taxa de GravidezRESUMO
During the last years, the use of circulating nucleic acids (microRNAs and cell-free DNA) as diagnostic and/or prognostic tools in cancerology was widely documented. Likewise, in obstetrics and gynecology, the development of non-invasive prenatal testing based on the assessment of these biomarkers confirmed their growing interest in this speciality. In human reproduction, several studies were interested in the microRNAs, small non-coding RNA sequences, present in the ovarian follicle and their implication in folliculogenesis. Some of these microRNAs, as well as the vesicles which transport them, are easily detectable in the bloodstream and could be used as reliable biomarkers of interest in infertility care. Cell-free DNA level varies according to physiopathology and reflect the proportion of apoptotic and/or necrotic events occurring in the body. As a result, its quantification could give an additional help to the practitioners for ovarian functional status evaluation. Furthermore, these circulating nucleic acids could also constitute new predictive biomarkers of oocyte and/or embryo quality and represent a promising perspective for the prevention of in vitro fertilization implantation failures. In conclusion, these circulating nucleic acids open the way to the development of new diagnostic and/or prognostic innovative tests in order to improve in vitro fertilization outcomes.
Assuntos
Biomarcadores/sangue , Fertilização in vitro , Ácidos Nucleicos/sangue , DNA/sangue , Feminino , Humanos , MicroRNAs/sangue , Folículo Ovariano/química , Ovário/fisiologia , Prognóstico , Resultado do TratamentoRESUMO
Embryo selection based exclusively on embryo morphological criteria does not allow currently to obtain satisfactory implantation rates. So, new time-lapse systems have been proposed to improve the rates of in vitro fertilization success. However, the profit/investment ratio of time-lapse systems and the interest of embryo morphokinetics evaluation remain clearly to be established by clinical, robust, prospective, and randomized trials. Consequently, morphological and morphokinetic approaches showed their limitations and justify the development of new non-invasive "omics" approaches. These approaches are very promising and have for main aim to identify new non-invasive biomarkers, in oocyte microenvironment and/or in embryo culture medium, predictive of oocyte and/or embryo quality as well as pregnancy rates. These approaches thus open the way to develop new diagnostic and/or prognostic tests for embryo viability based on the expression and/or the quantification of biomarkers of interest in assisted reproductive technology.
Assuntos
Transferência Embrionária/métodos , Embrião de Mamíferos/anatomia & histologia , Embrião de Mamíferos/fisiologia , Fertilização in vitro/métodos , Técnicas de Cultura Embrionária , Implantação do Embrião , Feminino , Humanos , Gravidez , Taxa de Gravidez , Imagem com Lapso de TempoAssuntos
Amônia/sangue , Doenças dos Bovinos/etiologia , Glycine max/efeitos adversos , Rúmen/metabolismo , Gastropatias/veterinária , Amônia/metabolismo , Animais , Análise Química do Sangue/veterinária , Bovinos , Doenças dos Bovinos/metabolismo , Feminino , Glycine max/metabolismo , Gastropatias/etiologia , Gastropatias/metabolismoRESUMO
BACKGROUND: Cattle are commonly fed soybean meal (SBM) and accidental intoxication sometimes occurs. OBJECTIVES: To describe the biologic and clinical features of SBM intoxication. ANIMALS: Four steers with ruminal cannula. METHODS: Controlled experimental trial. SBM was administered once at 1 and 2% of body weight (BW) via cannula at 2-month intervals. RESULTS: This study showed a 2-phase pathogenic course for 2% BW SBM intoxication. The 1st phase (until 10 hours post-administration) is restricted to ruminal modification with volatile fatty acid overproduction and moderate ruminal ammonia concentration. In the 2nd phase (12-22 hours post-administration), ruminal pH returned to initial values and marked ammonia accumulation occurred in blood, inducing severe metabolic alkalosis with hyperglycemia, hyperinsulinemia, and delayed aciduria (30-40 hours post-administration). Among the clinical signs, nervous signs were only observed during the period with increased plasma ammonia concentration. At 1% BW, ruminal and blood modifications were less pronounced than at 2% BW, and clinical signs were not observed. CONCLUSIONS AND CLINICAL RELEVANCE: Ammonia accumulation in blood during the second phase is the consequence of continued ammonia production, decreased carbohydrate fermentation, and overwhelming of hepatic detoxifying capacity. Because ammonia accumulation is associated with the clinical signs, treatment of SBM intoxication could be similar to treatment of urea intoxication, including rumenotomy, oral administration of cold water and vinegar, and measurement of ruminal pH.